J&J drug shows promise in high-risk prostate cancer – msnbc.com

(Reuters) – Adding Johnson & Johnson’s advanced prostate cancer drug, Zytiga, to hormone therapy before surgery has been shown for the first time to eradicate tumors in some men with high-risk forms of the disease. The mid-stage trial found that six months …

Posted in Uncategorized